A DNM1L GTPase Effector Domain Deletion Causes Intermediate Defects in Peroxisomal and Mitochondrial Dynamics and Reveals a Targetable Metabolic Vulnerability
Findings support a functional allelic spectrum in DNM1L-associated disease in which protein domain contributes to, but does not completely determine, functional severity.
Abstract
DNM1L encodes dynamin-related protein 1 (DRP1), a key GTPase regulating mitochondrial and peroxisomal dynamics. Pathogenic DNM1L variants are associated with a broad spectrum of neurodevelopmental and neurodegenerative disorders, with phenotypic severity varying by affected protein domain. While variants in the GTPase domain are typically associated with milder phenotypes and middle-domain variants with severe developmental and epileptic encephalopathy, the functional impact of GTPase effector domain (GED) variants remains less defined. Here, we describe four individuals harboring a recurrent heterozygous GED deletion (L700del) presenting with movement disorders and lacking severe infantile encephalopathy, consistent with an intermediate clinical phenotype. Patient-derived fibroblasts exhibited tubular peroxisomes and enlarged mitochondria, while Drosophila models demonstrated that DNM1LL700del has intermediate functional effects that were more pronounced than those of a GTPase-domain variant A192E but less severe than those of the middle-domain variant G350R. Comparison with another GED variant, Y691C, further demonstrated variant-specific differences in severity within the GED. Metabolic stress assays showed that L700del fibroblasts exhibited impaired growth under galactose conditions, consistent with increased vulnerability under conditions dependent on mitochondrial oxidative metabolism. Bezafibrate, a PPAR agonist that promotes mitochondrial biogenesis, partially rescued this growth defect. Together, these findings support a functional allelic spectrum in DNM1L-associated disease in which protein domain contributes to, but does not completely determine, functional severity. L700del represents an intermediate-strength allele associated with a movement-disorder phenotype and a pharmacologically modifiable metabolic vulnerability.
BACKGROUND
Variants in the dynamin 1-like (DNM1L) gene, which encodes dynamin-related protein 1 (Drp1), can cause encephalopathy due to defective mitochondrial and peroxisomal fission 1 (EMPF1) and optic atrophy 5 (OPA5), two neurodevelopmental disorders with distinct symptoms. Given the critical role of Drp1 in mitoch...
Shang-Sheng Dong, Yan-Juan Chen, Meng-Fang Yan et al.· European Journal of Medical...· 0 citations
Mitochondrial dynamics are essential for neuronal function, with dynamin-related protein 1 (DRP1), encoded by the
DNM1L
gene, playing a key role in mitochondrial fission. Pathogenic variants in
DNM1L
are associated with a spectrum of severe neurodevelopmental and neurodegenerative disorders. This study aime...
M. J. Herrero-Turrión, A. Hernández-Fabián, R. Gómez-Nieto et al.· Orphanet Journal of Rare Dis...· 0 citations
Pathogenic, bi-allelic variants in RMND1 typically manifest as an early-onset multisystemic mitochondrial disease, yet the consequences of RMND1 dysfunction in vivo remain poorly understood. To answer this question, we generated and characterized the first in vivo model of RMND1-related disease, carrying the recurrent...
Alba Pesini, M. Sánchez-Quintero, C. López-Gómez et al.· EMBO Molecular Medicine· 0 citations
Two compound heterozygous variants in the NDUFS1 gene in a patient presenting with optic atrophy are identified including the known variant c.64C>T p.(R22X) and a novel variant c.404G>A p.(G135D), associated with impaired complex I-mediated electron transfer and mitochondrial dysfunction, providing insights into the pa...
Zhen-Hui Liu, Yu-Jie Jin, Yan Li et al.· Biochimica et Biophysica Act...· 0 citations
A novel role for the mitochondrial resident protein ATAD3A is revealed in modulating lysosomal homeostasis through regulation of the mTORC1-TFEB axis, providing a mechanistic link between impaired mitochondrial and lysosomal homeostasis in a neurodevelopmental disorder.
Matthew B. McDougal, Abigail Sandoval, M. Kinter et al.· bioRxiv· 0 citations
SEC16A encodes a scaffold protein that organizes the endoplasmic reticulum (ER) exit sites, specialized ER subdomains that mediate export of newly synthesized proteins and regulate early secretory pathway steps. The role of SEC16A in human nervous system diseases has not been established yet. Here, we report six indivi...
Meng-Qi Ma, Xiao-Wei Lei, Juan Li et al.· Journal of Clinical Investig...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.